Composition

Each 100 g contains:
Nystatin ............................................................... 1 g
Iodochlorhydroxyquin ........................................ 3 g
Hydrocortisone acetate ...................................... 1 g

Therapeutic Indications

Inflammatory and pruritic dermatoses complicated by bacterial or fungal infections such as:
Secondary infected cutaneous candidiasis.
Infected eczema.
Napkin dermatitis.
Intertrigo.

Dosage and Administration

Apply a thin film to the affected area 2-3 times daily, or as directed by the physician.

Contraindications

Skin tuberculosis.
Most viral lesions (Herpes simplex).

Pharmacological Properties

NYSTAFORM combines the antifungal and antimicrobial properties of nystatin and iodochlorhydroxyquin together with the anti-inflammatory and antipruritic effects of hydrocortisone acetate. Nystatin provides specific anticandidal activity specially against Candida albicans.

Storage

Store at a temperature 15°C-25°C.

Packaging

NYSTAFORM Ointment: Tube of 20 g.